Brainsmiths
-
Franchise India Bureau Feb 28 2018 - 2 min readRivals in the past, Swiss drug maker Roche Pharma and India’s third-largest drug maker have combined to promote and distribute tocilizumab (Actemra) and Syndyma, the 2nd brand of Roche’s cancer therapy, bevacizumab (Avastin) in India. In a joint statement, the company said this partnership is in line with Roche and Cipla’s ...